Tech Company Financing Transactions
IDbyDNA Funding Round
ARTIS Ventures and Genesys Capital invested in a $20 million Series B funding round for IDbyDNA. The funding round was announced on 1/30/2020.
Transaction Overview
Company Name
Announced On
1/30/2020
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series B
Investors
ARTIS Ventures (Lead Investor) (Stuart Peterson)
Proceeds Purpose
This funding will be used to fuel growth of our Explify Software Platform into the worldwide infectious disease and microbiome testing markets.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
324 Ritch St.
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Undisclosed
Website
Email Address
Overview
IDbyDNA's mission is to help doctors and scientists to detect any pathogen in any sample, thereby removing barriers for the adoption of metagenomics in clinical settings, ultimately leading to faster public health responses during infectious disease outbreaks.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Guochun Liao
Chief Medical Officer
Robert Schlaberg
Chief Scientific Officer
Mark Yandell
General Manager
Jun Wang
VP - Bus. Development
Jeffrey Field
VP - Finance
Chris Minunni
VP - Marketing
Jen Bruursema
VP - Operations
Amy Davis
VP - Product Management
Qing Li
VP - Regulatory Affairs
Dina Hannah
Browse more venture capital transactions:
Prev: 1/30/2020: OpenPhone venture capital transaction
Next: 1/30/2020: Attentive venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs